Hemrajani Rekha
SEC insider (Form 3/4/5 filer). CIK 0001771213. Director at MAXCYTE, INC. (MXCT) and 3 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in NEW YORK, NY.
Companies Hemrajani Rekha has filed insider reports for
- MAXCYTE, INC. (MXCT): Director
- BioAge Labs, Inc. (BIOA): Director
- LB PHARMACEUTICALS INC (LBRX): Director
- ALX ONCOLOGY HOLDINGS INC (ALXO): Director
Hemrajani Rekha
CIK: 0001771213
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 17, 2026MXCT
MAXCYTE, INC.
AwardDirect30.4K shares- - Jun 10, 2026BIOA
BioAge Labs, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - Jun 3, 2026LBRX
LB PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
10K shares- - Jan 20, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
40.4K shares- - Sep 10, 2025LBRX
LB PHARMACEUTICALS INC
AwardDirectStock Option (Right to Buy)
22.4K shares- - Jun 25, 2025MXCT
MAXCYTE, INC.
SaleDirect10.7K shares at avg. $2.09$22K - Jun 18, 2025MXCT
MAXCYTE, INC.
AwardDirect29.2K shares- - Jun 5, 2025BIOA
BioAge Labs, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - Jan 21, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock Option (right to buy)
40.4K shares- - Dec 2, 2024ALXO
ALX ONCOLOGY HOLDINGS INC
PurchaseDirect30K shares at avg. $1.55$46K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  MXCT MAXCYTE, INC. | Award | 30,421 | - | $0 | Direct |
| Jun 10, 2026 |  BIOA BioAge Labs, Inc. | Award Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Jun 3, 2026 |  LBRX LB PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Jan 20, 2026 |  ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 40,400 | - | - | Direct |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | Award Stock Option (Right to Buy) | 22,449 | - | - | Direct |
| Jun 25, 2025 | MXCT MAXCYTE, INC. | Sale | 10,684 | $2.09 | $22,378 | Direct |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | Award | 29,210 | - | - | Direct |
| Jun 5, 2025 | BIOA BioAge Labs, Inc. | Award Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Jan 21, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock Option (right to buy) | 40,400 | - | - | Direct |
| Dec 2, 2024 | ALXO ALX ONCOLOGY HOLDINGS INC | Purchase | 30,000 | $1.55 | $46,404 | Direct |
1-10 of 13 transactions